Search research articles
Contact Us
Filters
Showing results (181-190 of 217) with videos related to
Page
of 22
Sort By:
Neuro-Oncology
|
March 4, 2008
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme
Vinay K Puduvalli, Pierre Giglio, Morris D Groves, et al.
Clinical Breast Cancer
|
August 6, 2018
Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution Experience
Rashmi K Murthy, Akshara S Raghavendra, Kenneth R Hess, et al.
Investigational New Drugs
|
January 6, 2019
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study
Clinton Yam, Francisco J Esteva, Miral M Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2005
Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years
James C Yao, Jennifer F Tseng, Samidha Worah, et al.
CA: a Cancer Journal for Clinicians
|
October 14, 2017
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
Jeffrey E Gershenwald, Richard A Scolyer, Kenneth R Hess, et al.
Oncotarget
|
November 21, 2017
Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience
Jennifer B Goldstein, Chad Tang, Kenneth R Hess, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 7, 2017
A Double-Blind, Randomized, Placebo-Controlled Trial of <i>Panax Ginseng</i> for Cancer-Related Fatigue in Patients With Advanced Cancer
Sriram Yennurajalingam, Nizar M Tannir, Janet L Williams, et al.
Neuro-Oncology
|
February 11, 2004
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study
Michael D Prados, W K A Yung, Kurt A Jaeckle, et al.
Investigational New Drugs
|
October 28, 2017
Radiomics to predict immunotherapy-induced pneumonitis: proof of concept
Rivka R Colen, Takeo Fujii, Mehmet Asim Bilen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 6, 2018
Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition
Xian Chen, Kwang-Huei Low, Angela Alexander, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 217) with videos related to
Sort By:
Page
of 22
Neuro-Oncology
|
March 4, 2008
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme
Vinay K Puduvalli, Pierre Giglio, Morris D Groves, et al.
Clinical Breast Cancer
|
August 6, 2018
Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution Experience
Rashmi K Murthy, Akshara S Raghavendra, Kenneth R Hess, et al.
Investigational New Drugs
|
January 6, 2019
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study
Clinton Yam, Francisco J Esteva, Miral M Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2005
Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years
James C Yao, Jennifer F Tseng, Samidha Worah, et al.
CA: a Cancer Journal for Clinicians
|
October 14, 2017
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
Jeffrey E Gershenwald, Richard A Scolyer, Kenneth R Hess, et al.
Oncotarget
|
November 21, 2017
Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience
Jennifer B Goldstein, Chad Tang, Kenneth R Hess, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 7, 2017
A Double-Blind, Randomized, Placebo-Controlled Trial of <i>Panax Ginseng</i> for Cancer-Related Fatigue in Patients With Advanced Cancer
Sriram Yennurajalingam, Nizar M Tannir, Janet L Williams, et al.
Neuro-Oncology
|
February 11, 2004
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study
Michael D Prados, W K A Yung, Kurt A Jaeckle, et al.
Investigational New Drugs
|
October 28, 2017
Radiomics to predict immunotherapy-induced pneumonitis: proof of concept
Rivka R Colen, Takeo Fujii, Mehmet Asim Bilen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 6, 2018
Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition
Xian Chen, Kwang-Huei Low, Angela Alexander, et al.
Page
of 22